Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sartorius AGSARTF 85 Operating Cash Flow per Share is $15.36 as of Jun. 2026. GuruFocus rates SARTF with a GF Score™ of 85/100 and a GF Value™ of $222.98. The stock has 6 warning signs investors should review. Among 651 Medical Devices & Instruments companies, Sartorius AG ranks worse than 62.67% on this metric.
Sartorius AG's operating cash flow per share for the
three
months ended in Jun. 2026 was $2.92.
Sartorius AG's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was $15.36.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sartorius AG was -0.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.60% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Sartorius AG's Operating Cash Flow per Share or its related term are showing as below:
SARTF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -28.1 Med: 18 Max: 52.8
Current: 4.1
During the past 13 years, Sartorius AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.80% per year. The lowest was -28.10% per year. And the median was 18.00% per year.
SARTF's 3-Year OCF Growth Rate is ranked worse than 62.67% of 651
companies
in the Medical Devices & Instruments industry
Industry Median: 12.5
vs SARTF: 4.10
Sartorius AG Operating Cash Flow per Share Related Terms
Sartorius AG Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Sartorius AG's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SARTF vs ISRG, BDX, RMD: Operating Cash Flow per Share Comparison
For the Medical Instruments & Supplies subindustry, Sartorius AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius AG Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sartorius AG's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.36
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $15.36 mean?
Sartorius AG (SARTF) has a Operating Cash Flow per Share of $15.36 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Sartorius AG and its competitors. According to the industry distribution chart, Sartorius AG ranks #408 out of 651 companies in the Medical Devices & Instruments industry, placing it in the top 62.7%.
Is Sartorius AG's Operating Cash Flow per Share too high?
Sartorius AG's current Operating Cash Flow per Share is $15.36. The Medical Devices & Instruments industry median Operating Cash Flow per Share is 12.50. Sartorius AG's value of $15.36 is 22.9% above this industry median. Based on the distribution chart, Sartorius AG ranks #408 out of 651 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sartorius AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Operating Cash Flow per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius AG ranks #408 out of 651 companies for Operating Cash Flow per Share. This places Sartorius AG in the lower half of its industry. The industry median Operating Cash Flow per Share is 12.50. Sartorius AG's value of $15.36 is 22.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.50, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius AG's current Operating Cash Flow per Share of $15.36 is 22.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Sartorius AG and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius AG's current Operating Cash Flow per Share is $15.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Sartorius AG (SARTF) has a current Operating Cash Flow per Share of $15.36. The stock's GF Value™ is $222.98, compared to a current price of $212.80 — trading 4.6% below its estimated fair value. The current Operating Cash Flow per Share is $15.36 and 22.9% above the Medical Devices & Instruments industry median of 12.50. Sartorius AG's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Sartorius AG (SARTF), the current Operating Cash Flow per Share is $15.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius AG (SARTF) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued.
The current stock price of $212.80 is trading 4.6% below its estimated GF Value™ of $222.98.
Key valuation signals for SARTF:
Operating Cash Flow per Share: $15.36
GF Value™: $222.98 vs. price of $212.80 (4.6% below fair value)
Industry Position: 22.9% above the Medical Devices & Instruments median (#408 of 651)
No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
85GF Score
Get the complete analysis for SARTF
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SARTF has been successfully added to your 
